Population
Patients with congestive heart failure
Design
Review
Authors
Loading...
May inform anti-cytokine monoclonal antibody trials in heart failure; leaves open clinical efficacy.
Understanding the involvement of proinflammatory cytokines in heart failure may enable future therapies using monoclonal antibodies to block disease progression.
Blum et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: